{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:24:43Z","timestamp":1783643083085,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Evidence from murine models and human post-mortem studies indicates that monoaminergic nuclei undergo degeneration at the pre-symptomatic stage of Alzheimer\u2019s disease (AD). Analysing 129 datasets from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) and relying on the Clinical Dementia Rating as group-defining instrument, we hypothesised that the MRI signal of monoaminergic nuclei would be a statistically significant predictor of memory decline in participants initially recruited in ADNI as healthy adults. As opposed to a group of cognitively stable participants, participants developing memory decline had reduced signal in the ventral tegmental area at baseline, before any evidence of functional decline emerged. These findings indicate that monoaminergic degeneration predates the onset of memory decline in an AD-centred initiative, with a crucial involvement of very-early changes of a dopaminergic region. This translates into potential informative avenues for pharmacological treatment of pre-symptomatic AD.<\/jats:p>","DOI":"10.1038\/s41598-020-71368-1","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T11:03:14Z","timestamp":1604055794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Reduced monoaminergic nuclei MRI signal detectable in pre-symptomatic older adults with future memory decline"],"prefix":"10.1038","volume":"10","author":[{"given":"Annalena","family":"Venneri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"71368_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack, C. R. Jr. et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 9, 119\u2013128 (2010).","journal-title":"Lancet Neurol."},{"key":"71368_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak, H., Thal, D. R., Ghebremedhin, E. & Del Tredici, K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 70, 960\u2013969 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"71368_CR3","doi-asserted-by":"publisher","first-page":"7829507","DOI":"10.1155\/2017\/7829507","volume":"2017","author":"T Chalermpalanupap","year":"2017","unstructured":"Chalermpalanupap, T., Weinshenker, D. & Rorabaugh, J. M. Down but not out: the consequences of pretangle Tau in the locus coeruleus. Neural Plast. 2017, 7829507 (2017).","journal-title":"Neural Plast."},{"key":"71368_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1365-2990.2008.00997.x","volume":"35","author":"LT Grinberg","year":"2009","unstructured":"Grinberg, L. T. et al. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer\u2019s disease. A precocious onset?. Neuropathol. Appl. Neurobiol. 35, 406\u2013416 (2009).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"71368_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0006-8993(92)90839-2","volume":"574","author":"RM Torack","year":"1992","unstructured":"Torack, R. M. & Miller, J. W. Hippocampal pyramidal cell response to 6-hydroxydopamine lesions of the rat ventral tegmental area. Brain Res. 574, 345\u2013348 (1992).","journal-title":"Brain Res."},{"key":"71368_CR6","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","volume":"8","author":"A Nobili","year":"2017","unstructured":"Nobili, A. et al. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat. Commun. 8, 14727 (2017).","journal-title":"Nat. Commun."},{"key":"71368_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","volume":"13","author":"P Theofilas","year":"2017","unstructured":"Theofilas, P. et al. Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery. Alzheimers Dement. 13, 236\u2013246 (2017).","journal-title":"Alzheimers Dement."},{"key":"71368_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neubiorev.2017.10.023","volume":"83","author":"KY Liu","year":"2017","unstructured":"Liu, K. Y. et al. Magnetic resonance imaging of the human locus coeruleus: a systematic review. Neurosci. Biobehav. Rev. 83, 325\u2013355 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"71368_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3233\/JAD-170364","volume":"60","author":"C Vakalopoulos","year":"2017","unstructured":"Vakalopoulos, C. Alzheimer\u2019s disease: the alternative serotonergic hypothesis of cognitive decline. J. Alzheimers Dis. 60, 859\u2013866 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"71368_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-171018","volume":"63","author":"M De Marco","year":"2018","unstructured":"De Marco, M. & Venneri, A. Volume and connectivity of the ventral tegmental area are linked to neurocognitive signatures of Alzheimer\u2019s disease in humans. J. Alzheimers Dis. 63, 167\u2013180 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"71368_CR11","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"71368_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000447057","volume":"41","author":"C Woolf","year":"2016","unstructured":"Woolf, C. et al. Can the Clinical Dementia Rating scale identify mild cognitive impairment and predict cognitive and functional decline? Dement. Geriatr. Cogn. Disord. 41, 292\u2013302 (2016).","journal-title":"Dement. Geriatr. Cognit. Disord."},{"key":"71368_CR13","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.neurobiolaging.2009.12.002","volume":"32","author":"T Schulte","year":"2011","unstructured":"Schulte, T. et al. Age-related reorganization of functional networks for successful conflict resolution: a combined functional and structural MRI study. Neurobiol. Aging 32, 2075\u20132090 (2011).","journal-title":"Neurobiol. Aging"},{"key":"71368_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.media.2013.02.006","volume":"17","author":"M Jorge Cardoso","year":"2013","unstructured":"Jorge Cardoso, M. et al. STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Med. Image Anal. 17, 671\u2013684 (2013).","journal-title":"Med. Image Anal."},{"key":"71368_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuroimage.2015.04.065","volume":"116","author":"V Beliveau","year":"2015","unstructured":"Beliveau, V. et al. Functional connectivity of the dorsal and median raphe nuclei at rest. Neuroimage 116, 187\u2013195 (2015).","journal-title":"Neuroimage"},{"key":"71368_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnagi.2017.00236","volume":"9","author":"T Ikuta","year":"2017","unstructured":"Ikuta, T. et al. Disconnectivity between dorsal raphe nucleus and posterior cingulate cortex in later life depression. Front. Aging Neurosci. 9, 236 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"71368_CR17","doi-asserted-by":"publisher","first-page":"E2000","DOI":"10.1073\/pnas.1206247109","volume":"109","author":"GS Kranz","year":"2012","unstructured":"Kranz, G. S., Hahn, A., Savli, M. & Lanzenberger, R. Challenges in the differentiation of midbrain raphe nuclei in neuroimaging research. Proc. Natl. Acad. Sci. U.S.A. 109, E2000 (2012).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"71368_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.neuroimage.2009.06.012","volume":"47","author":"NI Keren","year":"2009","unstructured":"Keren, N. I., Lozar, C. T., Harris, K. C., Morgan, P. S. & Eckert, M. A. In vivo mapping of the human locus coeruleus. Neuroimage 47, 1261\u20131267 (2009).","journal-title":"Neuroimage"},{"key":"71368_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2018.10.014","volume":"74","author":"KY Liu","year":"2019","unstructured":"Liu, K. Y. et al. In vivo visualization of age-related differences in the locus coeruleus. Neurobiol. Aging 74, 101\u2013111 (2019).","journal-title":"Neurobiol. Aging"},{"key":"71368_CR20","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/cercor\/bhv172","volume":"26","author":"S Zhang","year":"2016","unstructured":"Zhang, S., Hu, S., Chao, H. H. & Li, C. S. R. Resting-state functional connectivity of the locus coeruleus in humans: in comparison with the ventral tegmental area\/substantia nigra pars compacta and the effects of age. Cereb. Cortex 26, 3413\u20133427 (2016).","journal-title":"Cereb. Cortex"},{"key":"71368_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.neuroimage.2010.06.066","volume":"53","author":"H Gu","year":"2010","unstructured":"Gu, H. et al. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage 53, 593\u2013601 (2010).","journal-title":"Neuroimage"},{"key":"71368_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12993-015-0082-8","volume":"11","author":"JT Zhang","year":"2015","unstructured":"Zhang, J. T. et al. Decreased functional connectivity between ventral tegmental area and nucleus accumbens in Internet gaming disorder: evidence from resting state functional magnetic resonance imaging. Behav. Brain Funct. 11, 37 (2015).","journal-title":"Behav. Brain Funct."},{"key":"71368_CR23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","volume":"64","author":"JM Burns","year":"2005","unstructured":"Burns, J. M., Galvin, J. E., Roe, C. M., Morris, J. C. & McKeel, D. W. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 64, 1397\u20131403 (2005).","journal-title":"Neurology"},{"key":"71368_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","volume":"19","author":"JA Maldjian","year":"2003","unstructured":"Maldjian, J. A., Laurienti, P. J., Kraft, R. A. & Burdette, J. H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19, 1233\u20131239 (2003).","journal-title":"Neuroimage"},{"key":"71368_CR25","first-page":"877","volume":"44","author":"PR Corlett","year":"2004","unstructured":"Corlett, P. R. et al. Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning. Neuron 44, 877\u2013888 (2004).","journal-title":"Neuron"},{"key":"71368_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2463\/mrms.mp.2015-0132","volume":"16","author":"K Sakurai","year":"2017","unstructured":"Sakurai, K. et al. Volume of interest analysis of spatially normalized PRESTO imaging to differentiate between Parkinson disease and atypical parkinsonian syndrome. Magn. Reson. Med. Sci. 16, 16\u201322 (2017).","journal-title":"Magn. Reson. Med. Sci."},{"key":"71368_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.biopsych.2012.11.018","volume":"74","author":"JH Yoon","year":"2013","unstructured":"Yoon, J. H., Minzenberg, M. J., Raouf, S., D\u2019Esposito, M. & Carter, C. S. Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia. Biol. Psychiatry 74, 122\u2013129 (2013).","journal-title":"Biol. Psychiatry"},{"key":"71368_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuroimage.2008.05.055","volume":"42","author":"L Zaborszky","year":"2008","unstructured":"Zaborszky, L. et al. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage 42, 1127\u20131141 (2008).","journal-title":"Neuroimage"},{"key":"71368_CR29","first-page":"3881","volume":"27","author":"JL Cantero","year":"2017","unstructured":"Cantero, J. L., Zaborszky, L. & Atienza, M. Volume loss of the nucleus basalis of Meynert is associated with atrophy of innervated regions in mild cognitive impairment. Cereb. Cortex 27, 3881\u20133889 (2017).","journal-title":"Cereb. Cortex"},{"key":"71368_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0197-4580(90)90056-6","volume":"11","author":"OJ Vogels","year":"1990","unstructured":"Vogels, O. J. et al. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer\u2019s disease. Neurobiol. Aging 11, 3\u201313 (1990).","journal-title":"Neurobiol. Aging"},{"key":"71368_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1006\/nimg.2000.0582","volume":"11","author":"J Ashburner","year":"2000","unstructured":"Ashburner, J. & Friston, K. J. Voxel-based morphometry\u2013the methods. Neuroimage 11, 805\u2013821 (2000).","journal-title":"Neuroimage"},{"key":"71368_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","volume":"10","author":"JL Lancaster","year":"2000","unstructured":"Lancaster, J. L. et al. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 10, 120\u2013131 (2000).","journal-title":"Hum. Brain Mapp."},{"key":"71368_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrn.2016.165","volume":"18","author":"M Morales","year":"2017","unstructured":"Morales, M. & Margolis, E. B. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat. Rev. Neurosci. 18, 73\u201385 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"71368_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0306-4522(86)90156-9","volume":"18","author":"SE Loughlin","year":"1986","unstructured":"Loughlin, S. E., Foote, S. L. & Grzanna, R. Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets. Neuroscience 18, 307\u2013319 (1986).","journal-title":"Neuroscience"},{"key":"71368_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.1990.tb16870.x","volume":"600","author":"I T\u00f6rk","year":"1990","unstructured":"T\u00f6rk, I. Anatomy of the serotonergic system. Ann. N. Y. Acad. Sci. 600, 9\u201334 (1990).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"71368_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"71368_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/wcs.71","volume":"1","author":"V Goel","year":"2010","unstructured":"Goel, V. Neural basis of thinking: laboratory problems versus real-world problems. Wiley Interdiscip. Rev. Cogn. Sci. 1, 613\u2013621 (2010).","journal-title":"Wiley Interdiscip. Rev. Cogn. Sci."},{"key":"71368_CR38","first-page":"281","volume":"11","author":"MJ Betts","year":"2019","unstructured":"Betts, M. J. et al. Locus coeruleus MRI contrast is reduced in Alzheimer\u2019s disease dementia and correlates with CSF A\u03b2 levels. Alzheimers Dement. DADM 11, 281\u2013285 (2019).","journal-title":"Alzheimers Dement. DADM"},{"key":"71368_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2018.08.012","volume":"72","author":"L Serra","year":"2018","unstructured":"Serra, L. et al. In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer\u2019s disease. Neurobiol. Aging 72, 72\u201382 (2018).","journal-title":"Neurobiol. Aging"},{"key":"71368_CR40","first-page":"252","volume":"6","author":"A Martorana","year":"2014","unstructured":"Martorana, A. & Koch, G. Is dopamine involved in Alzheimer\u2019s disease?\u00a0Front. Aging Neurosci. 6, 252 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"71368_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.phrs.2018.01.016","volume":"130","author":"M D'Amelio","year":"2018","unstructured":"D\u2019Amelio, M., Puglisi-Allegra, S. & Mercuri, N. The role of dopaminergic midbrain in Alzheimer\u2019s disease: translating basic science into clinical practice. Pharmacol. Res. 130, 414\u2013419 (2018).","journal-title":"Pharmacol. Res."},{"key":"71368_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/156720501604190424114752","volume":"16","author":"DK Lahiri","year":"2019","unstructured":"Lahiri, D. K. Lessons from Alzheimer\u2019s disease (AD) clinical trials: instead of \u201cA-Drug\u201d, AD-D prevention to avert AD. Curr. Alzheimer Res. 16, 279\u2013280 (2019).","journal-title":"Curr. Alzheimer Res."},{"key":"71368_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/gps.545","volume":"17","author":"GK Wilcock","year":"2002","unstructured":"Wilcock, G. K., Birks, J., Whitehead, A. &\u00a0Grimley Evans, S. J. The effect of selegiline in the treatment of people with Alzheimer\u2019s disease: a meta-analysis of published trials. Int. J. Geriatr. Psychiatry 17, 175\u2013183 (2002).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"71368_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/138945012799499794","volume":"13","author":"O Weinreb","year":"2012","unstructured":"Weinreb, O., Amit, T., Bar-Am, O. & Youdim, M. B. H. Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer\u2019s disease treatment. Curr. Drug Targets 13, 483\u2013494 (2012).","journal-title":"Curr. Drug Targets"},{"key":"71368_CR45","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ejmech.2017.07.008","volume":"138","author":"HL Yang","year":"2017","unstructured":"Yang, H. L. et al. Design, synthesis and evaluation of Coumarin-Pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-\u03b2 aggregation for the treatment of Alzheimer\u2019s disease. Eur. J. Med. Chem. 138, 715\u2013728 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"71368_CR46","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/npp.2014.119","volume":"39","author":"G Koch","year":"2014","unstructured":"Koch, G. et al. Dopaminergic modulation of cortical plasticity in Alzheimer\u2019s disease patients. Neuropsychopharmacology 39, 2654\u20132661 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"71368_CR47","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1176\/appi.ajp.158.9.1517","volume":"158","author":"D Nagaraja","year":"2001","unstructured":"Nagaraja, D. & Jayashree, S. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am. J. Psychiatry 158, 1517\u20131519 (2001).","journal-title":"Am. J. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71368-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:09:27Z","timestamp":1670364567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71368-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71368"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71368-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"14 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18707"}}